TGFB1 and chronic kidney disease: On the other hand, Xie et al. observed that the administration of soluble Klotho to CKD patients prevented the progression of uremic cardiomyopathy [29] and Yin and collaborators proposed that kidney fibrosis might be abrogated by a fine-tuned control of the pro-fibrotic TGFβ functions [32].